Related Concept Videos
01:22Chronic Obstructive Pulmonary Disease
2.4K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.4K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
3.6K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.6K
01:29Chronic Obstructive Pulmonary Disease-V: Management
3.1K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.1K
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
4.3K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
4.3K
01:30Chronic Obstructive Pulmonary Disease-V: Nursing Management
5.1K
Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
Assessment
5.1K
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
3.6K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
3.6K
You might also read
Related Articles
Articles linked to this work by shared authors, journal, and citation graph.
Sort by
Same author
Co-occurrence and multi-system clustering of respiratory and allergic symptoms in Polish school-aged children: a Global Asthma Network cross-sectional study.
Advances in medical sciences·2026
Same author
Dietary sugar and soft drink consumption in relation to atopic disease in children: evidence from the Polish global asthma network study.
BMC pulmonary medicine·2026
Same author
Assessment of Conventional Oxygen Therapy, High-Flow Nasal Cannula, and Non-Invasive Ventilation to Secure Bronchofiberoscopy in Patients with Respiratory Acidosis: A Narrative Review and a Proposal for a Protocol in View of a Randomized Multicenter Study.
Journal of clinical medicine·2026
Related Experiment Video
Updated: Jan 25, 2026
08:17
Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure
Published on: August 25, 2017
11.5K
Chronic Obstructive Pulmonary Disease and Platelet Count.
Szymon Skoczyński1, Damian Krzyżak2, Aleksandra Studnicka2
1Department of Pneumology, Upper-Silesian Medical Center, Medical University of Silesia, Katowice, Poland. simon.mds@poczta.fm.
Advances in Experimental Medicine and Biology
|May 4, 2019
Summary
Chronic obstructive pulmonary disease (COPD) does not affect human platelet counts. However, in COPD patients, platelet numbers inversely correlate with red blood cell indices like hemoglobin and hematocrit.
Area of Science:
- Hematology
- Pulmonology
- Medical Research
Background:
- Recent murine studies suggest platelet maturation occurs in the lungs.
- This implies chronic lung diseases might impact platelet production and count.
- Chronic obstructive pulmonary disease (COPD) is a prevalent chronic lung condition.
Purpose of the Study:
- To investigate potential changes in platelet count in patients with COPD.
- To determine if COPD influences platelet maturation and circulating platelet levels in humans.
Main Methods:
- A comparative study involving 44 patients with stage II-IV COPD and 48 age/gender-matched controls without respiratory disease.
- Platelet counts were measured and compared between the COPD and control groups.
- Associations between platelet count and red blood cell parameters (hemoglobin, hematocrit, red cell count) were analyzed in COPD patients.
Main Results:
- No significant difference in mean platelet count was found between COPD patients (231 ± 80 x 10^3/μL) and controls (223 ± 63 x 10^3/μL).
- A significant inverse association was observed between platelet count and hemoglobin (r = -0.57), hematocrit (r = -0.40), and red cell count (r = -0.51) in COPD patients.
- These associations were not present in the non-COPD control group.
Conclusions:
- COPD does not appear to influence platelet count in humans.
- The inverse relationship between platelet count and red blood cell indices in COPD patients warrants further investigation.